证券研究报告 | 2025年08月26日 登康口腔（001328.SZ） 优于大市 电商渠道持续放量，产品升级迭代驱动毛利率上行 二季度业绩稳定增长。公司 2025H1 实现营收 8.42 亿/yoy+19.72%；归母净 利润 0.85 亿/yoy+17.59%。单 Q2 营业收入 4.11 亿/yoy+20.11%；归母净利 润 0.42 亿元/yoy+19.66%，扣非归母净利润同比增长 24.02%。公司持续发力 电商渠道，并成功打造高毛利大单品，驱动整体业绩量价齐升。 分品类看，成人牙膏作为核心品类，实现营收 6.77 亿/yoy+23.00%，是增长 的主要驱动力，收入占比提升至 80.43%。成人牙刷业务保持稳健，实现营收 0.83 亿/yoy+4.16%。新兴品类表现亮眼，电动牙刷实现营收 0.07 亿 /yoy+37.33%；口腔医疗与美容护理实现营收 0.21 亿/yoy+54.85%，展现出 强劲的增长潜力。儿童口腔护理业务中，儿童牙膏营收同比微增 1.15%，儿 童牙刷营收同比下滑 4.59%。分渠道看，2025H1 电商及其他渠道实现营收 3.25 亿元，同比大幅增长 81.13%， ...

| | | 08月25日目标价涨幅排名 | | | | | --- | --- | --- | --- | --- | --- | | 证券代码 | 证券名称 | 机构 | 最新评级 | 最高目标价 | 目标涨幅 | | | | | | (元) | (%) | | 000998 | 隆平高科 | 中国国际金融 | 跑赢行业 | 14.00 | 38.75 | | 601918 | 新集能源 | 中信证券 | 买入 | 9.00 | 37.40 | | 000786 | 北新建材 | 天风证券 | 买入 | 36.90 | 36.57 | | 688123 | 聚辰股份 | 华创证券 | 强推 | 112.61 | 34.48 | | 301308 | 江波龙 | 华泰证券 | 买入 | 129.10 | 33.46 | | 000786 | 北新建材 | 中国国际金融 | 跑赢行业 | 36.00 | 33.23 | | 688382 | 益方生物 | 野村东方国际证券 | 增持 | 56.19 | 33.21 | | ୧୦3505 | 金石资源 | 中信证券 | 北) | 22.00 | 28.65 | | ...

2025年1至6月份，登康口腔的营业收入构成为：个护用品-洗护用品占比99.89%，其他业务占比0.11%。 截至发稿，登康口腔市值为76亿元。 每经头条（nbdtoutiao）——A股成交连续8天破2万亿元，券商招聘也来了！行业巨头秋招"求才"，25个 岗位都有什么特点？ （记者 张喜威） 每经AI快讯，登康口腔（SZ 001328，收盘价：44.34元）8月25日晚间发布公告称，公司第八届第二次 董事会会议于2025年8月25日在公司办公楼三楼二会议室以现场表决的方式召开。会议审议了《关于 <2025年半年度报告>及其摘要的议案》等文件。 ...

证券研究报告·公司点评报告·个护用品 稳健医疗（300888） 2025 年中报点评：双主业并驾齐驱，稳健向好 2025 年 08 月 25 日 增持（维持） | [Table_EPS] 盈利预测与估值 | 2023A | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | --- | | 营业总收入（百万元） | 8,185 | 8,978 | 11,219 | 12,866 | 14,764 | | 同比（%） | (27.89) | 9.69 | 24.96 | 14.68 | 14.75 | | 归母净利润（百万元） | 580.40 | 695.38 | 1,044.52 | 1,237.42 | 1,494.17 | | 同比（%） | (64.84) | 19.81 | 50.21 | 18.47 | 20.75 | | EPS-最新摊薄（元/股） | 1.00 | 1.19 | 1.79 | 2.12 | 2.57 | | P/E（现价&最新摊薄） | 42.23 | 35.25 | 23.47 | 19.81 | 1 ...

公司报告 | 半年报点评 依依股份（001206） 证券研究报告 全球供应优势逐步显现 公司发布 2025 年中期报告 25Q2 公司实现收入 4.0 亿元，同比-6.1%；归母净利润 0.5 亿元，同比-9.1%； 扣非归母净利润 0.4 亿元，同比-15.2%； 25H1 公司实现收入 8.9 亿元，同比+9.3%；归母净利润 1.0 亿元，同比+7.4%； 扣非归母净利润 0.9 亿元，同比+9.1%。 目前我国宠物行业正处于高速发展期，养宠人数逐渐增多，宠物主消费意 愿和消费能力进一步提升，我们认为公司自有品牌布局有望享受行业红利。 调整盈利预测，维持"买入"评级 上半年受到关税政策影响对美暂缓出货，目前公司订单情况稳定，生产有 序进行，对美业务已经恢复正常，此外公司大力拓展非美地区，如欧洲、 东南亚等地区，努力降低市场风险。 25Q2 毛利率 19.1%，同比-0.4pct，归母净利率 11.9%，同比-0.4pct，盈利 能力保持稳定。 25H1 分配现金股利 0.44 亿元，分红比例 43%。 25H1 分品类来看，宠物垫收入 7.6 亿，同比+7.3%，毛利率 17.5%，同比 -0.6pct ...

Investment Rating - The investment rating for the company is "Buy" (maintained) [5] Core Views - The company is actively expanding its offline channels and is expected to see strong performance from its new youth product series [5] - The company achieved a total revenue of 895 million yuan in the first half of 2025, representing a year-on-year growth of 20.31%, and a net profit attributable to shareholders of 188 million yuan, up 4.16% year-on-year [8] - The company has launched over 40 new or upgraded products in the first half of 2025, focusing on sunscreen products for infants and youth, thereby expanding its product matrix [8] - The gross profit margin for the first half of 2025 increased by 0.4 percentage points to 59.0%, while the net profit margin decreased by 3.2 percentage points to 20.9% [8] - The company is expected to achieve net profits of 330 million yuan, 410 million yuan, and 490 million yuan from 2025 to 2027, with corresponding year-on-year growth rates of 11%, 23%, and 19% [8] Financial Summary - The company’s revenue is projected to grow from 1,318 million yuan in 2024 to 2,302 million yuan in 2027, with growth rates of 27.61%, 24.81%, 20.96%, and 15.68% respectively [7][9] - The net profit attributable to shareholders is forecasted to increase from 300 million yuan in 2024 to 488 million yuan in 2027, with growth rates of 32.80%, 11.13%, 22.61%, and 19.42% respectively [7][9] - The company’s return on equity (ROE) is expected to rise from 14.43% in 2024 to 18.56% in 2027 [7][10]

Investment Rating - The report maintains a "Buy" rating for the company [4][6]. Core Views - The company experienced a slowdown in performance in the first half of 2025, with a revenue of 895 million yuan, representing a year-on-year increase of 20.31%, and a net profit of 188 million yuan, up by 4.16% [1]. - The second quarter of 2025 saw a revenue of 655 million yuan, an increase of 13.46%, but a decline in net profit to 143 million yuan, down by 0.85% [2]. - The company plans to focus on its infant care segment in the second half of the year to drive performance [2]. Financial Performance Summary - In the first half of 2025, the company reported a gross margin of 58.01%, down by 0.63 percentage points, and a net profit margin of 20.95%, down by 3.25 percentage points [3]. - The sales expense ratio increased to 30.25% in the first half of 2025, up by 1.52 percentage points, due to increased marketing efforts on platforms like Douyin [3]. - The company expects revenues for 2025 to reach 1.62 billion yuan, with net profits projected at 339 million yuan, reflecting a growth rate of 13.01% [5]. Product Performance Breakdown - The revenue from mosquito repellent products was 332 million yuan, up by 13.83%, accounting for 50.65% of total revenue [2]. - Infant care products generated 226 million yuan, a 22.89% increase, representing 34.45% of total revenue, driven by higher-priced new products [2]. - Essential oil revenue decreased by 15.64% to 81 million yuan, accounting for 12.37% of total revenue, attributed to changes in product sales structure [2]. Future Outlook - The company anticipates continued growth in market share due to its strong brand image, product innovation, and operational capabilities [4]. - Revenue projections for 2025-2027 are set at 1.62 billion yuan, 1.99 billion yuan, and 2.45 billion yuan, respectively, with corresponding net profits of 339 million yuan, 419 million yuan, and 516 million yuan [4].

Investment Rating - The report maintains a "Buy" rating for the company [6] Core Views - The company achieved a revenue of 895 million yuan in H1 2025, representing a year-over-year increase of 20.31%, with a net profit of 188 million yuan, up 4.16% year-over-year [1] - The growth in the baby care business is driven by new product launches and increased marketing efforts, with over 40 new products introduced in the first half of the year [2] - The company is expected to see a recovery in performance in the second half of the year due to new product launches and increased investment across all channels [2] Financial Performance - In Q2 2025, the company reported a revenue of 655 million yuan, a year-over-year increase of 13.46%, but a slight decline in net profit by 0.85% [1] - The gross profit margin for H1 2025 decreased by 0.63 percentage points to 58.01%, primarily due to increased sales and management expenses [1] - The company plans to distribute a mid-term dividend of 2.00 yuan per 10 shares, totaling 80.92 million yuan [1] Revenue Breakdown - For H1 2025, revenue from mosquito repellent, baby care, and essential oil products was 375 million yuan, 405 million yuan, and 92 million yuan, respectively, with year-over-year growth rates of 13.43%, 38.73%, and -14.60% [2] - The online and offline channels saw revenue growth of 20% and 21% respectively in H1 2025, with significant contributions from new partnerships and channel expansions [3] Future Projections - The company is projected to achieve revenues of 1.62 billion yuan, 1.97 billion yuan, and 2.41 billion yuan for the years 2025, 2026, and 2027, with year-over-year growth rates of 22.5%, 22.2%, and 22.2% respectively [4] - Net profit is expected to reach 330 million yuan, 420 million yuan, and 519 million yuan for the same years, with growth rates of 10.5%, 26.0%, and 24.3% respectively [4]

Investment Rating - The report maintains a "Recommended" rating for the company, indicating a positive outlook for its stock performance relative to the benchmark index [4][5]. Core Insights - The company achieved a revenue of 895 million yuan in H1 2025, representing a year-on-year growth of 20.31%. The net profit attributable to shareholders was 188 million yuan, up 4.16% year-on-year [1]. - The baby and child care segment continues to show strong growth, with revenue reaching 405 million yuan, a year-on-year increase of 38.73%. The product matrix has been enhanced with over 40 new or upgraded products launched in H1 2025 [2]. - The company is expanding its target audience from infants to teenagers, introducing products such as acne treatment and skincare for adolescents, which reflects its strategy to meet unmet consumer needs [2]. Financial Performance - The gross profit margin for H1 2025 was 58.01%, a slight decrease of 0.63 percentage points year-on-year. The net profit margin for the same period was 20.95%, down 3.25 percentage points year-on-year [3]. - The company’s sales, management, and R&D expense ratios for H1 2025 were 30.25%, 1.81%, and 1.83%, respectively, indicating a slight increase in sales expenses compared to the previous year [3]. - The forecast for net profit attributable to shareholders for 2025-2027 is projected to be 335 million, 434 million, and 552 million yuan, with respective year-on-year growth rates of 11.6%, 29.7%, and 27.0% [4][5]. Market Position and Strategy - The company is solidifying its online market position while actively expanding its offline channels, with significant contributions from new partnerships, such as with Sam's Club [4]. - The report highlights the company's leadership in the baby mosquito repellent market and its proactive approach in the baby care sector, which is expected to unlock further growth potential [4].

Investment Rating - The report maintains a "Buy" rating for the company with an expected relative return of over 20% within the next six months [4]. Core Views - The company is focusing on brand building and channel expansion, increasing marketing and promotional efforts to enhance brand influence and market share [1][3]. - The company is optimizing its product structure, particularly in the health and hygiene segment, with significant growth in sanitary napkin sales and the introduction of new health-oriented products [2][3]. - The company is experiencing a mixed performance in online and offline sales channels, with offline sales showing strong growth while online sales faced temporary challenges due to public sentiment [3]. Financial Performance Summary - In Q2 2025, the company reported revenue of 770 million, a year-on-year increase of 0.2%, and a net profit attributable to shareholders of 57 million, a decrease of 25.5% [1]. - For the first half of 2025, the company achieved revenue of 1.76 billion, up 15.1%, and a net profit of 188 million, an increase of 4.6% [1]. - The gross margin for Q2 2025 was 53.1%, down 1.3 percentage points year-on-year, while the net profit margin was 7.5%, down 2.6 percentage points [1]. Product and Market Strategy - The company is focusing on the sanitary napkin category, with revenue of 1.688 billion in the first half of 2025, a year-on-year increase of 19.93% [2]. - The company is prioritizing the development of new products in the health sector, particularly those addressing consumer needs and pain points, with plans to leverage e-commerce for consumer feedback and product testing [2]. Sales Channel Performance - Offline sales in the first half of 2025 reached 1.133 billion, a year-on-year increase of 39.8%, while online sales were 592 million, a decrease of 9.44% [3]. - The company is adapting its strategies based on regional market conditions, with significant growth in areas outside its core provinces [3]. Financial Forecast - The report adjusts profit forecasts for the company, projecting net profits of 370 million, 480 million, and 620 million for 2025, 2026, and 2027 respectively, with corresponding P/E ratios of 35X, 27X, and 21X [4][8].